These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31 related articles for article (PubMed ID: 10898418)
1. Pro32Pro33 mutations in the integrin β3 PSI domain result in αIIbβ3 priming and enhanced adhesion: reversal of the hypercoagulability phenotype by the Src inhibitor SKI-606. Oliver KH; Jessen T; Crawford EL; Chung CY; Sutcliffe JS; Carneiro AM Mol Pharmacol; 2014 Jun; 85(6):921-31. PubMed ID: 24695082 [TBL] [Abstract][Full Text] [Related]
2. Increased activity of phosphatase PP2A in the presence of the PlA2 polymorphism of alphaIIbbeta3. Wang H; Yan B; Satterwhite LL; Ma Q; Goldschmidt-Clermont PJ Biochem Biophys Res Commun; 2008 Feb; 367(1):72-7. PubMed ID: 18155662 [TBL] [Abstract][Full Text] [Related]
3. PlA polymorphism of glycoprotein IIIa and risk of adverse events after coronary stent placement. Kastrati A; Koch W; Gawaz M; Mehilli J; Böttiger C; Schömig K; von Beckerath N; Schömig A J Am Coll Cardiol; 2000 Jul; 36(1):84-9. PubMed ID: 10898417 [TBL] [Abstract][Full Text] [Related]
4. Effect of the Pl(A2) alloantigen on the function of beta(3)-integrins in platelets. Bennett JS; Catella-Lawson F; Rut AR; Vilaire G; Qi W; Kapoor SC; Murphy S; FitzGerald GA Blood; 2001 May; 97(10):3093-9. PubMed ID: 11342435 [TBL] [Abstract][Full Text] [Related]
5. The GPIIIa (beta3 integrin) PlA polymorphism in the early development of coronary atherosclerosis. Mikkelsson J; Perola M; Penttilä A; Goldschmidt-Clermont PJ; Karhunen PJ Atherosclerosis; 2001 Feb; 154(3):721-7. PubMed ID: 11257275 [TBL] [Abstract][Full Text] [Related]